Chiki Shimbunsha, the Tokyo Standard and Fukuoka-listed publisher of local community newspapers (code 2164), said on July 15 that it is pressing ahead with takeover defenses against MTM Capital Co., Ltd., a day after MTM published a notice stating it intends to make a formal acquisition proposal sometime between mid- and late August 2026.
The company says its board activated a poison pill on July 14 after concluding that MTM and unnamed "joint actors" had built a combined voting stake of 20% or more by June 25, 2026, without submitting the letter of intent required under Chiki Shimbunsha's shareholder-approved takeover-defense policy. The independent committee recommended triggering the countermeasures, and the board says it will keep the process moving whether or not MTM ultimately makes its proposal or files the required paperwork.
| Threshold | Value | Why It Matters |
|---|---|---|
| Poison pill trigger | 20% of voting rights | Chiki Shimbunsha says MTM and joint holders crossed this level without filing the required letter of intent |
| Alleged combined stake | 30.95% (as of June 25, 2026) | The company's own count of voting rights held by MTM and its joint actors |
| Mandatory tender-offer trigger | 30% of voting rights | Any further share purchases above this level must go through a formal tender offer under Japan's Financial Instruments and Exchange Act, in the company's view |
Chiki Shimbunsha's own count puts the MTM-linked stake at 30.95% of voting rights as of June 25, with purchases continuing since that date. That figure matters because it sits above the 30% line that triggers Japan's mandatory tender-offer rule: once a holder and its "specially related persons" pass that threshold, any further purchase, even a single share, is supposed to go through a formal tender offer rather than open-market buying. The company notes that a tender-offer filing also requires proof of funding, such as a bank balance certificate, and warns that announcing a bid without that backing could amount to spreading false information under the Financial Instruments and Exchange Act.
A second complaint concerns disclosure quality. MTM's most recent large-shareholding report, filed after a May 1, 2026 rule change requiring bidders to spell out the specifics of any "material proposal," reportedly listed only the boilerplate purpose of "making a material proposal," and MTM then posted its acquisition-notice document separately on its own website. Chiki Shimbunsha says the timing and vagueness of that sequence raise doubts about compliance with the law.
The fight has also turned personal. MTM's notice reportedly argues that Chiki Shimbunsha's spending to counter so-called wolf-pack shareholders amounts to illegal benefit provision. Chiki Shimbunsha rejects that framing, citing a final 2018 Tokyo High Court ruling in the Izu Shaboten Resort case, which found that paying reasonable advisory fees to respond to a hostile buyer does not breach a director's duty of care. The company is demanding MTM delete the disputed language immediately, and says it may otherwise pursue a criminal defamation claim.
As of the July 15 notice, MTM has not submitted any letter of intent under the defense policy, and no tender offer has been filed. What happens next depends on whether MTM proceeds with its stated mid-to-late August timetable, and on whether it complies with the intent-filing and tender-offer steps that Chiki Shimbunsha says are now mandatory.